kentucky tirzepatide lawsuit Zepbound Lawsuit [2026]

Ozempic, Wegovy, Mounjaro and Other GLP-1 Agonists Side Effects Canadian Class Action

20.83

★★★★☆4.8 (126)

FDA has announced that the shortage of #tirzepatide, the ingredient in Lilly's Mounjaro and Zepbound, has been resolved. Compounding #pharmacies are required to cease production of compounded versions of tirzepatide within the

20.42

★★★★★4.9 (98)

🚨Pharmacists & Prescribers: Compounding GLP-1 meds like semaglutide & tirzepatide is generally prohibited, unless strict exceptions are met (e.g., FDA shortage + clinical necessity for an individual patient). Violations may lead to

29.03

★★★★★5.0 (157)

The lawsuits allege Novo Nordisk and Indianapolis-based Eli Lilly and Company downplayed vision loss risks associated with popular medications including Ozempic, Wegovy and Lilly's Mounjaro. Read more at the link in bio

28.71

★★★★★4.7 (84)

The lawsuits allege Novo Nordisk and Indianapolis-based Eli Lilly and Company downplayed vision loss risks associated with popular medications including Ozempic, Wegovy and Lilly's Mounjaro. Read more at the link in bio

23.41

★★★★★4.9 (203)

Connecticut Attorney General warning about the use of non-FDA approved weight-loss injections, consequences

22.83

★★★★★5.0 (176)

Weight-loss drugs could see a shortage until 2025, makers predict

23.88

★★★★★4.8 (132)